Canada Markets open in 6 hrs 47 mins

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
30.44-0.36 (-1.17%)
At close: 04:00PM EDT
30.18 -0.26 (-0.85%)
After hours: 07:59PM EDT
Sign in to post a message.
  • B
    BobC
    Corporate Insiders have accumulated Shares Worth $213.5K in the Last 3 Months.
  • R
    Rob
    How many Nobel prizes did Dr. Bredt say would be coming for this breakthrough again? Does he still think its a Ludacris hypothesis after the potential has been corroborated by research done in Japan, Canada and Yale University?
  • A
    Abdul
    A lot buying pressure.
  • M
    Mick
    Did Musk just buy in ?
  • b
    bezel
    We are in a good place. Relax, enjoy, be patient and know we may have the best medicine for the worst disease. Hope for me is financial but more for the afflicted.
  • s
    syed
    Nice recovery and solid close 🚀
  • A
    Archisaurus
    I'm not much of a GIF poster... However, I couldn’t resist tweaking and posting this image in honor of a certain, very enthusiastic, SAVA Ultra-Long… Have a great weekend @Alex and all!

    https://drive.google.com/file/d/1Gg4tG0OBi8echbabLdkzWFrmCfD_oQrD/view?usp=sharing
  • J
    Jake
    Buying tomorrow and thursday, if it's under my $31.69 average. I'm feeling very good about this.
  • A
    Alex
    As every one knows there is time value to money and investments, the shorts artificially took away the the value of sava stock with their lies, FUD, and phantom shares through weekly options market…pay back will come in the form of 20-50x back our money! Shorts are TOAST!
  • M
    Miller
    So fired up to hear CMS and P3 enrollment progress!! Wondering if any have been able to enroll yet in Korea. Can't wait for this update. Good enrollment progress will absolutely fry Shorty. Get Shorty!!
  • b
    bezel
    This was a good week. Steady gains on low volume with increased % needed to short. Data will drive our future and we need to see more soon to keep the momentum going. Good luck to all longs and have a fun weekend.
  • I
    IBGoodinTX
    I sent an e-mail to the Alzheimer's Association yesterday suggesting that one of the best ways they could help AD patients and their families would be to encourage them to enroll in the stage 3 clinical trials that are now enrolling. I also sent links to both Hilary Metz interviews for them to see beyond the fake controversies.
  • A
    Alex
    The very recent FLNA study (Increased insoluble Filamin A concentrations in post-mortem brain tissue during mid-stage Alzheimer’s disease) along with the recent JApanese research on FLNA along with Yale…..are burying the shorts false thesis that Sava has made up science. I’ve never felt more confident on Sava’s prospects, then you add in all the replicated unprecedented data from Sava….it’s a buy at will situation all day Long! Shorts are TOAST!
  • S
    Somaze
    let us close the day in green, buy buy buy family.
  • C
    Carl
    Filamin A = AD as published by multiple studies. Yale study confirms that Simufilam binds to Fimamin A with high affinity. P2 results and Metz father. Korean parallel study. People are connecting the dots and buying in.
  • J
    John
    Congrats to those who didn’t listen to MichaelS and BioClinicalRS!
  • J
    Jake
    Closing in on my $31.XX average. Not selling for 3 years
  • B
    Brad
    Biogen terminated a clinical trial of Aduhelm recently (6/21). It targeted 6,000 participants worldwide, but only 29 enrolled for EIGHT months. You can google it and find several articles about it.
  • A
    Archisaurus
    A new 6/23/22 cohort study finds: "Associations Between Handgrip Strength and Dementia Risk" ...Based on how strongly I'm gripping/holding onto my SAVA shares... I definitely have hope for a future without AD as I currently know and fear it.
  • R
    Richard16006
    SAVA's saga has taught me more about media, shorts, FUD, and my fellow investors than anything in recent memory and I'm a better investor for it.